10.1016/j.bmc.2008.08.060
The research centers on the synthesis and assessment of sulfonamide analogs of KRN7000, which are known for activating natural killer (NK) T cells. The goal was to create compounds that could selectively stimulate the production of Th2-biased cytokines to potentially alleviate autoimmune diseases and enhance transplantation tolerance. The study involved synthesizing a range of sulfonamide analogs, including both aromatic and aliphatic types, using phytosphingosine as the starting material and employing various chemical reactions such as protection and deprotection of hydroxyl groups, glycosidation, and sulfonamide formation. The synthesized analogs were then tested for their bioactivity using mouse spleen cells in vitro to evaluate the production of Th1 and Th2 cytokines. The analysis was performed using a cytometric bead array (CBA) to quantify IFN-?, IL-4, and IL-13 levels, allowing the researchers to assess the cytokine profile induced by each analog. The findings indicated that most of the analogs were effective in promoting Th2-biased cytokine production, with certain analogs showing particularly high IL-4/IFN-? ratios, suggesting their potential in modulating immune responses towards a Th2 phenotype.